| Medical and Health Sciences | Lifetime | 119 | US 67 | 99.99 |
| Economics and Finance | Lifetime | 311 | US 200 | 99.75 |
| Medical and Health Sciences | 2021-2025 | 66 | US 28 | 99.99 |
| Economics and Finance | 2021-2025 | 261 | US 37 | 99.18 |
| Oncology | Lifetime | 3 | US 2 | 99.99 |
| Econometrics and Quantitative Economics | Lifetime | 179 | US 112 | 99.79 |
| Epidemiology | Lifetime | 272 | US 138 | 99.66 |
| Pulmonary and Respiratory Medicine | Lifetime | 388 | US 212 | 99.50 |
| Pathology and Forensic Medicine | Lifetime | 621 | US 285 | 97.19 |
| Cancer Research | Lifetime | 565 | US 297 | 96.34 |
| Health | Lifetime | 705 | US 379 | 94.57 |
| Oncology | 2021-2025 | 7 | US 3 | 99.96 |
| Epidemiology | 2021-2025 | 158 | US 50 | 99.00 |
| Econometrics and Quantitative Economics | 2021-2025 | 195 | US 21 | 99.19 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 338 | US 106 | 96.76 |
| Medical Physiology | 2021-2025 | 389 | US 141 | 94.60 |
| Health | 2021-2025 | 399 | US 162 | 86.34 |
| Global Cancer Incidence and Screening | Lifetime | 1 | US 1 | 99.99 |
| Colorectal Cancer Screening and Detection | Lifetime | 2 | US 1 | 99.98 |
| Economic and Financial Impacts of Cancer | Lifetime | 1 | US 1 | 99.98 |
| COVID-19 and healthcare impacts | Lifetime | 3 | US 2 | 99.93 |
| Multiple and Secondary Primary Cancers | Lifetime | 2 | US 1 | 99.98 |
| Cancer Risks and Factors | Lifetime | 9 | US 5 | 99.88 |
| Cervical Cancer and HPV Research | Lifetime | 46 | US 23 | 99.66 |
| Genetic factors in colorectal cancer | Lifetime | 68 | US 36 | 99.65 |
| Healthcare Policy and Management | Lifetime | 177 | US 132 | 98.83 |
| Gastric Cancer Management and Outcomes | Lifetime | 430 | US 144 | 99.04 |
| BRCA gene mutations in cancer | Lifetime | 141 | US 75 | 98.83 |
| Breast Cancer Treatment Studies | Lifetime | 306 | US 157 | 99.00 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 575 | US 268 | 98.50 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 768 | US 352 | 98.27 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 473 | US 237 | 98.50 |
| Esophageal Cancer Research and Treatment | Lifetime | 408 | US 158 | 97.73 |
| Prostate Cancer Treatment and Research | Lifetime | 577 | US 315 | 98.40 |
| Smoking Behavior and Cessation | Lifetime | 316 | US 229 | 97.14 |
| Acute Lymphoblastic Leukemia research | Lifetime | 657 | US 317 | 97.71 |
| Colorectal Cancer Surgical Treatments | Lifetime | 738 | US 220 | 96.82 |
| Health disparities and outcomes | Lifetime | 961 | US 410 | 96.89 |
| Global Health Care Issues | Lifetime | 727 | US 296 | 95.34 |
| Advances in Oncology and Radiotherapy | Lifetime | 328 | US 163 | 94.00 |
| Cutaneous Melanoma Detection and Management | Lifetime | 902 | US 384 | 94.42 |
| Male Breast Health Studies | Lifetime | 717 | US 281 | 59.87 |
| COVID-19 and healthcare impacts | 2021-2025 | 2 | US 1 | 99.91 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 1 | US 1 | 99.87 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 2 | US 1 | 99.93 |
| Cancer Risks and Factors | 2021-2025 | 1 | US 1 | 99.80 |
| Global Cancer Incidence and Screening | 2021-2025 | 2 | US 1 | 99.94 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 2 | US 1 | 99.83 |
| Cervical Cancer and HPV Research | 2021-2025 | 18 | US 9 | 99.28 |
| Healthcare Policy and Management | 2021-2025 | 90 | US 72 | 95.93 |
| Genetic factors in colorectal cancer | 2021-2025 | 196 | US 84 | 95.66 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 675 | US 205 | 93.91 |
| Advances in Oncology and Radiotherapy | 2021-2025 | 149 | US 66 | 89.67 |
| Healthcare cost, quality, practices | 2021-2025 | 186 | US 86 | 89.41 |
| Smoking Behavior and Cessation | 2021-2025 | 254 | US 168 | 92.74 |
| Cancer Diagnosis and Treatment | 2021-2025 | 381 | US 97 | 84.03 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 987 | US 456 | 88.10 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 947 | US 397 | 88.03 |
